Categories: Health

Scientists Discover Main Driver of Early-Stage Lung Cancer

Researchers at the University of Texas MD Anderson Cancer Centre have discovered that inflammation may play a key role in driving the earliest stages of lung cancer.

By creating high-resolution cellular and molecular visual maps of lung cancer before and during its development, the team found that targeting proinflammatory pathways could serve as a potential early intervention strategy.

The study generated spatial transcriptomic maps in precancerous and more advanced stages of lung cancer to provide a deeper understanding of early lung cancer development. The research was led by Humam Kadara, Ph.D., professor of Translational Molecular Pathology, and Linghua Wang, M.D., Ph.D., professor of Genomic Medicine, associate member of the James P. Allison Institute and focus area co-lead with the Institute for Data Science in Oncology.

“We find that the earliest cells that give rise to lung cancer are in regions with very high inflammation and are surrounded by proinflammatory cells. Targeting inflammation by neutralising a driver called IL-1B reduces these precursor cells of lung cancer,” Kadara said. “Our work paves the way for targeting inflammation to intercept the earliest stages of lung cancer and impact patient lives.”

Spatial transcriptomic maps provide a visual representation of where and how genes are expressed within tissue samples. By characterising the cells and genes within precursor lesions – early-stage changes in tissues that could develop into cancer – researchers can identify potential targets for early intervention.

The researchers generated spatial transcriptomic maps of 56 human precursor lesions and advanced lung cancer samples from 25 patients. They validated their findings using an independent cohort of 36 lesions from 19 patients, providing 486,519 spots and 5.4 million cells for analysis.

The researchers were able to highlight certain molecular and inflammatory changes and characteristics that can distinguish between precursor cells and advanced lung cancer.

The study revealed that proinflammatory regions within early lesions, containing tumour-associated alveolar cells, are more active in the initial phases of cancer development and remain consistent in laboratory models, indicating that inflammation in these regions likely initiates tumour formation.

The findings show that targeting inflammation alone or in combination with immunotherapy may be promising early interception strategies for lung cancer.

From Emirates 24/7 website

manager

Recent Posts

Abu Dhabi Hosts Leading International Surgeons for 4th Emirates International Colorectal Congress

Five-day scientific and surgical training programme highlights advances in robotic surgery, colorectal cancer treatment and…

23 hours ago

Saudi German Health UAE Joins Global Leaders of Military Medicine at ICMM Abu Dhabi 2026, Showcasing UAE Healthcare Excellence on the World Stage

Saudi German Health UAE Joins the World’s Leading Military Medicine Experts and Leaders as the…

2 weeks ago

Abu Dhabi Surgeons Remove Rare 4.4kg Cancerous Tumour Larger Than a Newborn Baby in Complex Six-Hour Operation

A 49-year-old Pakistani expat makes a remarkable recovery after surgeons at NMC Royal Hospital, Khalifa…

2 weeks ago

Born 8 Weeks Early: Triplets Return Home After Specialised NICU Care at Emirates Specialty Hospital

Three premature babies return home after approximately one month of specialised neonatal care, highlighting the…

2 weeks ago

Emirates Specialty Hospital Expands Cancer Care Services in Dubai with Opening of Dedicated Chemotherapy Unit

New facility at Dubai Healthcare City aims to improve access to specialised cancer treatment, bringing…

1 month ago

When Rheumatoid Arthritis Threatened Her Independence: How the Right Diagnosis Helped Her Get Her Life Back

For a 45-year-old UAE resident, persistent pain and swelling turned out to be rheumatoid arthritis.…

1 month ago